Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?

Area of Science:

• Immunology
• Oncology
• Preclinical Research

Background:

• Multiple myeloma (MM) often affects older adults, coinciding with immunosenescence, increasing infection and cancer risk.
• The MM tumor microenvironment and chemotherapy exacerbate immune system defects during disease progression.
• Understanding MM-induced immune dysfunction is critical for effective treatment strategies.

Purpose of the Study:

• To review the role of mouse models in advancing MM research and immunotherapy development.
• To evaluate the utility of immunodeficient versus immunocompetent models for MM studies.
• To explore personalized medicine approaches for MM treatment.

Main Methods:

• Review of existing literature on mouse models in multiple myeloma research.
• Analysis of immunocompetent models (e.g., 5T series, Vk*MYC) for MM studies.
• Discussion of immune profiling, humanized mice, and 3D culture systems.

Main Results:

• Mouse models have significantly contributed to understanding MM-related immune defects and advancing immunotherapeutics.
• Immunocompetent models provide valuable insights into both adaptive and innate immune responses against MM.
• Immunodeficient models may have limitations in fully recapitulating MM's immune landscape.

Conclusions:

• Immunocompetent mouse models are increasingly important for preclinical MM research.
• Immune profiling and advanced models (humanized mice, 3D cultures) hold promise for personalized MM medicine.
• Further research using appropriate models is essential for optimizing MM immunotherapies.